Inovio Pharmaceuticals
INO
#9810
Rank
NZ$0.17 B
Marketcap
NZ$1.65
Share price
4.34%
Change (1 day)
-62.95%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): NZ-$3.11

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.26. In 2025 the company made an earnings per share (EPS) of NZ-$3.22 an increase over its 2024 EPS that were of NZ-$7.03.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.11-3.39%
2025NZ-$3.22-54.18%
2024NZ-$7.03-35.14%
2023NZ-$10.84-56.62%
2022NZ-$24.99-19.54%
2021NZ-$31.0635.9%
2020NZ-$22.85-11.57%
2019NZ-$25.8415.24%
2018NZ-$22.42-2.78%
2017NZ-$23.066.93%
2016NZ-$21.57134.88%
2015NZ-$9.18-29.51%
2014NZ-$13.03-57.34%
2013NZ-$30.54146.55%
2012NZ-$12.3920.83%
2011NZ-$10.25-29.41%
2010NZ-$14.52-48.48%
2009NZ-$28.1910%
2008NZ-$25.6311.11%
2007NZ-$23.06-41.3%
2006NZ-$39.30-66.91%
2005NZ-$118.74110.61%
2004NZ-$56.38-61.63%
2003NZ-$146.93186.67%
2002NZ-$51.26
2001N/A-100%
2000NZ-$41.00-63.64%
1999NZ-$112.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.54-577.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.85-463.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$4.63 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-169.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.69-274.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$5.93 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA